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A B S T R A C T
The goal of this study was to evaluate how self-rated health (SRH) and objective measures of health (biomarkers)
are associated, and if this association varies by gender, age, and socioeconomic position (measured by household
income). Data come from the UK Household Longitudinal Study nurse visit (2010–2012), including a re-
presentative sample of adults in Great Britain (N=15 687 maximum sample). SRH was assessed by the question
“In general, would you say your health is excellent, very good, good, fair, or poor?” and dichotomized into good or
poor. Indices were created for four biomarker categories based on the aspects of health they are likely to reflect,
including visible weigh-related, fitness, fatigue, and disease risk biomarkers. Logistic regression models were run
with SRH as the outcome and each biomarker index as a predictor, adjusting by gender, age, and income.
Further, interaction terms between each biomarker index and gender, age, and income (independently) were
added to test for effect modification. All biomarker indices were associated with SRH in expected directions, with
the fitness index most strongly predicting SRH. Gender, age, or income modified the associations between SRH
and all biomarker indices to different extents. The association between the visible weight-related biomarker index
(including body mass/fat variables) and SRH was stronger for women than men and for those in higher income
groups than lower income groups. Income also modified the association between SRH and the fitness biomarker
index, whereas age modified the association between SRH and the fatigue biomarker index. When using SRH to
investigate health inequalities, researchers and policy makers should be clear that different social groups may
systematically consider different dimensions of health when reporting their SRH.
Introduction
Self-rated health (SRH) is the most widely used proxy for health
status in medical sociology research (Jylhä, 2009). Usually assessed
with one question (e.g. “Overall, how would you rate your health?”),
SRH is easy and cheap to collect and has been consistently linked to
objective health measures (Christian et al., 2011; Jylhä, Volpato, &
Guralnik, 2006; Leshem-Rubinow et al., 2015; Shanahan, Bauldry,
Freeman, & Bondy, 2014; Tanno et al., 2012) and mortality (Idler &
Benyamini, 1997; Lima-Costa, Cesar, Chor, & Proietti, 2012a). How-
ever, research has shown that the way people interpret and respond to
the SRH question varies by age (Shooshtari, Menec, & Tate, 2007),
gender (Benyamini, Leventhal, & Leventhal, 2000; Jylhä, Guralnik,
Ferrucci, Jokela, & Heikkinen, 1998), and socioeconomic position (SEP)
(Dowd & Zajacova, 2010). Jylhä et al. (Jylhä et al., 1998) highlights
that several dimensions may be considered when rating one's health –
including medical and nonmedical factors – but “(SRH) has to be un-
derstood as a summary measure of all the dimensions of health that are
relevant to the individual respondent (emphasis added)” and, therefore,
highly variable. Given the ubiquity of SRH in medical sociology re-
search, public health policy and practice, it is crucial to understand how
the meaning of SRH may vary by population sub-groups and the con-
sequences of this for studying health inequalities.
Using data from Understanding Society – the UK Household
Longitudinal Study (UKHLS), the objectives of this study were to: 1)
evaluate how responses to SRH vary by underlying biomarker levels,
and 2) evaluate if the association between SRH and biomarkers is
modified by age, gender, and SEP (measured by household income).
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T
Biomarkers are objectively-measured markers of physiological systems
which include physical measures (e.g. weight, height, blood pressure)
and blood analytes (e.g. hemoglobin, c-reactive protein). Whereas
previous research linking SRH with biomarkers levels has treated bio-
markers as subclinical values/conditions of which participants are
mostly unaware (e.g. Jylhä et al., 2006), this “invisibility” is not ne-
cessarily true. Biomarkers can also reflect visible health conditions, for
example obesity. In addition, even if the respondent does not know
their exact value for a given biomarker, they may feel symptoms of
underlying diseases (e.g. fatigue) or may have a doctor's diagnosis of a
health condition (e.g. diabetes, high blood pressure) (Idler & Kasl,
1991; Jylhä, 2009). We have grouped biomarkers into four categories
(visible weight-related, fitness, fatigue, and disease risk) reflecting different
ways they may make the respondent feel and hence assess their health,
and assessed whether their association with SRH is modified by age,
gender, and/or SEP.
Background
In 2009, Jylhä developed a conceptual framework to understand the
thought processes and decisions involved when answering the SRH
question (Jylhä, 2009). Jylhä argues that there are different stages in-
volved in the process of self-assessment. When asked to rate their own
health, a person begins by assessing health as a concept: what does it
mean for them and which health components are most relevant to them
(Jylhä, 2009). This conceptualization is influenced by contextual and
cultural factors, including the individual's demographic and social
characteristics. In the second stage, individuals put their health in
perspective considering the individual's life stage and also compared to
peers: how is my health considering my age, previous health status and
expected future, how does it compare to that of peers based on age,
gender, socioeconomic condition, etc. (Jylhä, 2009). This stage can be
influenced not only by who the individuals choose as their reference
groups, but also by their mental state and their positive vs. negative
disposition. Finally, individuals decide how to fit these decisions into
the proposed self-rated scale; this in turn is influenced by cultural
conventions in expressing positive vs. negative opinions (Jylhä, 2009).
Therefore, it is expected that people's responses to the SRH question
will vary not only by age, gender, and SEP, but also by cohort, culture,
and social networks. Given these complexities, Jylhä (2009) argues that
SRH should be understood as both a subjective and contextual self-as-
sessment, and as an indicator of somatic and mental state.
Previous to Jylhä’s conceptual model, other researchers such as
Blaxter (1990) and van Dalen, Williams, and Gudex (1994) made efforts
to understand the decisions made when one rates their own health,
including different definitions of health for subgroups of age, gender,
and SEP. By using a series of qualitative and quantitative questions,
their research points to different dimensions of health – including
functionality, fitness, absence of illness, and psychosocial factors –
having varying importance for specific population subgroups (Blaxter,
1990; van Dalen et al., 1994). Moreover, people's responses vary if
defining health for oneself vs. others (Blaxter, 1990; van Dalen et al.,
1994).
Blaxter's research was based on The Health and Lifestyle Survey, a
national survey of adults aged>18 years in England, Wales and
Scotland in 1984–1985 (Blaxter, 1990). Among other things, survey
participants were asked two sets of open-ended questions regarding
their definition of health: (1) “Think of someone you know who is very
healthy. Who are you thinking of? How old are they? What makes you
call them healthy?” and (2) “At times people are healthier than at other
times. What is it like when you are healthy?” Blaxter found that re-
sponses differed by participant age, gender, and SEP. Among younger
people, physical fitness seemed to be the most important definition of
health, whereas it was the least favored concept for participants aged
over 60, both when defining health for oneself or others. Younger men,
in particular, also spoke of health in terms of physical strength and
fitness, whereas women discussed physical fitness in terms of outward
appearance, with being or feeling slim used to describe a healthy person.
On the other hand, energy was the word most frequently used by all
women and older men when describing health. Health as function was
more often mentioned among older people. Health as not being ill was
most commonly used to describe health in others, and more commonly
mentioned for those with higher education and income. Among
working-age men, particularly those who did manual work, health was
often defined as being able to do hard work. Interestingly, at all ages but
particularly among the elderly, those who were suffering from chronic
conditions were less likely to define their health in terms of (lack of)
illness. As Blaxter points out, “if illness symptoms are a taken for
granted experience, or disease is seen as the norm, then health has to be
defined in other ways” (Blaxter, 1990, pp. 21–22).
Regarding socioeconomic differences in SRH, Adams and White
(2006) used data from the 1998 Health Survey for England to evaluate
if the association between SRH and objective health measures (i.e.
systolic blood pressure and body mass index (BMI)) varied by occupa-
tional social class. They found that, within the “very good or good” SRH
category, those in the manual social class (compared to non-manual)
were more likely to have higher blood pressure and BMI, with no such
difference in the “less than good” SRH group; this suggested, the au-
thors concluded, that the way people rank their health varies by social
class (Adams & White, 2006). Similarly, Dowd and Zajacova (2010)
found that the association between SRH and biomarkers varied by
educational attainment among a nationally representative sample of US
adults, with more pronounced educational differences in biomarker
levels among those rating their health as “excellent.” Similar findings
have been reported when looking at the predictive power of SRH for
mortality, with a lower predictive power for those in disadvantaged
socioeconomic groups and a graded difference in the strength of the
association between the three socioeconomic groups studied (Lima-
Costa et al., 2012b).
More recent studies also highlight that the way different subgroups
rate their health may change over time. For example, the rise in both
obesity prevalence and ubiquity of health messages focused on weight-
related healthy behaviors (e.g. fruit and vegetable consumption, em-
phasis on physical activity) may affect the way people perceive and
rank their health (Altman, Van Hook, & Hillemeier, 2016). Altman et al.
(2016) argue that more recent cohorts would be more likely to take into
account their own weight status negatively when ranking their health.
However, this is not necessarily true as increases in obesity over time
may lead to a higher social acceptability of larger body types (Burke,
Heiland, & Nadler, 2010; Langellier, Glik, Ortega, & Prelip, 2014).
Based on previous research, in particular that of Blaxter (1990), we
anticipated that the association between SRH and biomarkers will vary
based on the type of biomarker under consideration, as well as by
gender, age, and SEP. Therefore, we grouped available biomarkers into
four categories based on the aspects of objective health they are likely
to reflect, grounded on previous literature as well as on the authors'
previous experience with biomarker data. The four categories included
(see also Table 1): visible weight-related biomarkers (to self and others;
called visible hereafter for simplification), including all biomarkers re-
lated to weight and body mass/fat (body mass index, waist cir-
cumference, and % body fat); fitness biomarkers, including heart rate,
grip strength, and lung function variables; fatigue biomarkers, including
c-reactive protein, fibrinogen, hemoglobin, ferritin, and cytomegalo-
virus infection; and disease risk biomarkers, including biomarkers that
may be markers of underlying conditions (blood pressure, lung func-
tion, cholesterol and triglycerides, and glycated hemoglobin [HbA1c]).
We hypothesized that gender, age, and SEP will modify SRH- bio-
marker associations within the four biomarker groups as follows:
(1) The association between SRH and biomarkers for women, com-
pared to men, will be: a) stronger for visible biomarkers, b) weaker
for fitness biomarkers, and c) stronger for fatigue biomarkers.
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(2) The association between SRH and biomarkers for older people,
compared to working-age adults, will be: a) weaker for fitness bio-
markers, b) stronger for fatigue biomarkers, and c) weaker for dis-
ease risk biomarkers.
(3) The association between SRH and biomarkers for people with lower
SEP, compared to higher, will be: a) weaker for visible biomarkers,
b) stronger for fitness biomarkers, c) stronger for fatigue biomarkers,
and d) weaker for disease risk biomarkers.
Methods
Data source
Data for this analysis comes from Understanding Society: the UK
Household Longitudinal Study (UKHLS; https://www.
understandingsociety.ac.uk/; University of Essex, 2015), which began
in 2009 and includes a number of different samples (Knies, 2015).
Specifically, this project is based on data from the General Population
Sample (GPS) and British Household Panel Survey (BHPS) samples in
waves 2 and 3 (2010–2012) respectively, which additionally included
data from a Nurse Health Assessment (Knies, 2015; University of Essex,
2014). Detailed information on data collection procedures for UKHLS
and the Nurse Health Assessment can be found elsewhere (Benzeval,
Davillas, Kumari, Lynn, & Institute for Social and Economic Research
(ISER), 2014; Knies, 2015; McFall, Petersen, Kamiska, Lynn, & Institute
for Social and Economic Research (ISER), 2014).
The Nurse Health Assessment took place approximately 5 months
after the main interviews for waves 2 or wave 3 from 2010 to 2012;
eligibility criteria for participation included completion of the most
recent main interview in English; being 16 or older; and not being
pregnant (McFall et al., 2014). Only participants living in England,
Wales, and Scotland were included as nurse recruitment proved diffi-
cult in Northern Ireland. In the second year of interviewing, only 81%
of the GPS sample were randomly selected to take part due to shortages
of qualified nurse interviewers. UKHLS participants fulfilling eligibility
criteria were contacted via post and telephone calls to set up a home
visit with the nurse. At the time of the visit, the nurse explained the
protocol for health measures and blood sample collection and provided
participants with an oral and written consent forms, respectively. Par-
ticipants could decline any procedure or measurement at any time.
During the nurse visit, participants received feedback on their anthro-
pometric and blood pressure measures. Blood samples were not ana-
lyzed at the time and hence no feedback from them was possible All
participants also received a £10 voucher upon completion of the nurse
visit, as a thank you for participating.
From an eligible sample of 35 875 participants, 20 644 completed
the health measures (57.5% response rate) and 13 517 provided blood
(37.7% response rate) (Benzeval et al., 2014; McFall et al., 2014);
subsequently blood samples were analyzed for a range of key analytes,
with sample size further varying by each biomarker measure (Table 1).
Data management
This analysis is cross-sectional, so all variables are taken from the
same wave for a given participant – wave 2 (GPS participants) or wave 3
(BHPS participants). Our dependent variable was SRH, assessed by the
question “In general, would you say your health is excellent, very good,
good, fair, or poor?” SRH was dichotomized into good (including those
who responded excellent, very good, or good) and poor (included those
who responded fair or poor). Our independent variables included most
biomarkers assessed in UKHLS, including a range of disease markers
and body function measures, as listed in Table 1. Protocols and pro-
cedures related to these measurements can be found in detail elsewhere
(Benzeval et al., 2014; McFall et al., 2014), with a summary of their use,
measurement method, exclusion criteria, and operationalization in-
cluded in Table 1.Ta
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Indices were created for each of the four biomarker groups by
classifying individuals into sex-specific tertiles for each of the included
variables (Table 2) and then summing the scores, whereby higher scores
indicate worse health outcomes. For example, within the visible bio-
marker group, individuals were assigned as being in the lowest, middle,
or highest (sex-specific) tertile for each of the variables included – BMI,
waist circumference, % body fat – and the scores were then summed,
with an index ranging from 3 (lowest tertile on all variables) to 9
(highest tertile on all variables). For biomarker groups where higher
values of certain variables indicate better health outcomes (e.g. grip
strength in the fitness group), reverse coding was applied.
Gender (women vs. men), age, and household income, as a marker
of SEP, were also included in the analysis to assess their potential
moderation of the SRH – biomarker associations. Analyses were re-
stricted for those age 25 years and higher so that most individuals will
have completed education. For moderation analysis, age was categor-
ized as working-age (25–60 years) vs. retirement-age (> 60 years; 95th
percentile= 80 years, highest value=102 years). Household monthly
net equivalised income (i.e. adjusted by household size using OECD
scale, in £) was categorized in tertiles based on sample distribution.
Educational attainment standardized by age and categorized in tertiles
was also considered as a measure of SEP and assessed in moderation
analysis. However, since the results with education were very similar to
those obtained with income, we only present results with household
income as a marker for SEP.
Statistical analysis
All analyses were carried out in SAS v9.4 using sample weights to
adjust for the complex sample design and likelihood of being included
in the Nurse Health Assessment (Benzeval et al., 2014; Knies, 2015).
Descriptive statistics were used to characterize the sample. The asso-
ciation between SRH (dependent variable) and each biomarker
(independent variables), as well as the four biomarker indices, was
assessed using logistic regression models while adjusting for gender,
age (continuous), and household income.
To assess if the association between SRH and each biomarker group
(i.e. visible, fitness, fatigue, and disease risk) was modified by gender, age,
and/or household income, interactions terms between each biomarker
index and each modifying variable were added to the logistic regression
models. If the interaction term was significant (p < 0.10), the asso-
ciation between SRH and the biomarker index was deemed to be
modified by the given variable. Stratified logistic regression models by
gender, age (categorical), and household income (in tertiles) were then
conducted to assess how the association between SRH and each bio-
marker index varied for women vs. men; working-age vs. retired-age
adults; and high-income vs. middle-income vs. low-income groups.
Results
Table 3 displays sample characteristics; the mean (SE) for each
biomarker and biomarker index for the sample as a whole and by
gender, age, and household income; and the associations between SRH
and each biomarker and biomarker index. The sample was 56% female
and over two-thirds were working-age (aged 25–60 years). For all
biomarker indices, means varied by gender (women higher than men),
age (retired-age higher than working-age), and household income
(highest in the low-income, followed by the middle-income, and lowest
in the high-income); however, these differences were small.
Overall, we found that all the biomarker group indices were nega-
tively associated with SRH, with higher indices (reflecting worse health
outcomes) associated with lower odds of reporting good health. The
fitness index was more strongly associated with SRH than the other
indices: a one-unit increase in the fitness index (i.e. worse fitness out-
comes) was associated with 20% lower odds of reporting good health
(Table 3). Following were the visible and the fatigue indices: a one-unit
increase in either of the two indices was associated with 16% lower
odds of reporting good health. On the other hand, a one-unit increase in
the disease risk index was associated with only 11% lower odds of re-
porting good health.
Almost all the individual biomarker-SRH associations were sig-
nificant and in the expected direction (e.g. higher BMI, waist cir-
cumference, and %body fat associated with lower odds of reporting
good health). Only ferritin was not significantly associated with SRH,
whereas total cholesterol was associated with SRH in the unexpected
direction (higher total cholesterol, higher odds of reporting good
health). Total cholesterol includes both LDL and HDL cholesterol,
though, and HDL is positively associated with SRH, driving the re-
lationship of total cholesterol and SRH in the positive direction as well.
The visible individual biomarkers were more strongly associated with
SRH compared to the other biomarkers. For example, the odds of re-
porting good health among the obese (defined based on BMI, Table 1)
were 56% lower compared to those with a normal weight (Table 3).
Fig. 1 shows the results from the stratified analysis, displaying
moderation effects by gender, age, and household income in the asso-
ciation between SRH and each biomarker group index. In terms of
moderation by gender, we found that the association between SRH and
the visible index was significantly stronger for women than men (in-
teraction for visible index*gender p-value = 0.0088). Upon gender
stratification, we found that a one-unit increase in the visible index was
associated with 18% lower odds of reporting good health for women vs
13% lower odds for men. We found a similar gender modification for
the disease risk index (interaction p-value=0.0799): a one-unit in-
crease in the disease risk index was associated with 13% lower odds of
reporting good health for women vs. 9% lower odds for men (Fig. 1).
For the fitness and fatigue indices, the association between SRH and
these indices seemed stronger for men than women in magnitude, but
the gender interactions were not significant (p-value= 0.3548 and p-
value= 0.1203, respectively).
Table 2
Cut-off points for sex-specific tertiles for the creation of the visible weight-related,
fitness, fatigue and disease risk indices.
Women Men
Lowest
tertile cut-
off
Highest
tertile cut-
off
Lowest
tertile cut-
off
Highest
tertile cut-
off
VISIBLE WEIGHT-RELATED BIOMARKERS
Body Mass Index (kg/
m2)
24.9 29.8 26.0 29.7
Waist circumference
(cm)
82.7 95.4 94.3 105.0
%Body fat (%BF) 33.7 40.9 19.6 27.3
FITNESS BIOMARKERS
Heart rate (bpm) 65.0 73.5 62.0 71.5
Grip strength (kg) 24.0 30.0 38.0 47.0
FEV1% 87.5 100.4 85.7 98.9
FVC% 92.2 104.5 90.7 103.1
FATIGUE BIOMARKERS
C-reactive protein (mg/
L)
0.9 2.4 0.8 2.0
Fibrinogen (g/L) 2.6 3.0 2.5 2.9
Hemoglobin (g/L) 127.0 135.0 141.0 150.0
Ferritin (μg/L) 50.0 103.0 114.0 202.0
DISEASE RISK BIOMARKERS
SBP (mmHg) 114.5 129.5 123.5 135.5
DBP (mmHg) 68.0 77.0 69.5 79.0
FEV1% 88.1 101.0 87.0 100.3
FVC% 92.9 104.9 92.1 104.4
Total cholesterol
(mmol/L)
5.0 5.9 4.9 5.9
HDL cholesterol (mmol/
L)
1.5 1.9 1.2 1.5
Triglycerides (mmol/L) 1.1 1.7 1.4 2.2
HbA1c (mmol/mol) 34.0 38.0 35.0 38.0
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In terms of age moderation, we found that the association between
SRH and the fatigue index was significantly stronger for the retired-age
group, compared to those in the working-age group (interaction p-value
for fatigue index*age = 0.0176). A one-unit increase in the fatigue index
was associated with 22% lower odds of reporting good health for those
in the retired-age group compared to 14% lower odds in the working-
age group (Fig. 1). No significant age modification was found for the
other biomarker indices.
We observed income moderation for the visible, fitness and disease
risk indices, with stronger associations with SRH in the high-income vs.
the low-income groups (interaction p-value=0.0013, p-
value= 0.0102, and p-value=0.0854, respectively). A one unit in-
crease in the visible, fitness and disease risk indices was associated with
18%, 23%, and 11% lower odds of reporting good health for those in
the high-income group, compared to 13%, 17%, and 9% lower odds for
those in the low-income group, respectively. In addition, for the disease
risk index, those in the middle-income group had a significantly
stronger association between disease risk index and SRH (13% lower
odds of reporting good health) vs. those in the high-income group (11%
lower odds; interaction p-value=0.0811).
Discussion
The aim of this study was to investigate the association between
SRH and a range of biomarkers in order to understand differential re-
porting of SRH in social surveys. We grouped biomarkers into four
categories (visible, fitness, fatigue, and disease risk) and examined whe-
ther their association with SRH was modified by gender, age, and in-
come among a sample of adults in Britain. We found that SRH was
associated with the majority of the biomarkers under study in the ex-
pected direction, with the fitness index having the largest impact on the
way people rate their health. The visible biomarkers, individually, also
had strong associations with SRH. Moreover, we found some mod-
ification effects by gender, age, and income, with mixed results re-
garding support for our hypotheses.
Our finding that SRH was significantly associated with objectively
measured biomarkers has support in the literature (Christian et al.,
2011; Jarczok et al., 2015; Jylhä et al., 2006; Saudny, Cao, & Egeland,
2012; Undén et al., 2007). Jylhä et al. (2006) found that SRH was
significantly associated with albumin, hemoglobin, white cell count,
HDL-cholesterol, and creatinine among a sample of older adults in three
U.S. states. Similarly, Saudny et al. (Saudny et al., 2012) found that
waist circumference, triglyceride levels, and CRP were associated with
SRH among a sample of Canadian Inuit. Jarczok et al. (Jarczok et al.,
2015), on the other hand, found that heart rate variability was the only
biomarker related to SRH among a convenience sample in Southern
Germany; they found no association between SRH and inflammatory
markers, blood pressure, and blood lipids. However, our paper goes
beyond these previous analyses by trying to conceptualize biomarker
groups as reflecting different dimensions of health and evaluating how
these different health dimensions might be associated with self-ratings
of health.
Our finding that the visible biomarkers were strongly associated with
SRH compared to the other biomarker types could be explained by the
current abundance of health messages related to obesity and its nega-
tive consequences (Altman et al., 2016). People's exposure to obesity-
related health messages may not have an effect on their actual body
weight, but it may influence their knowledge and social norms re-
garding body weight and thus influence the way they rank their health
(Medic et al., 2016). Similar conclusions could be reached regarding the
fitness biomarkers, with strong media emphasis on fitness for health.
Alternatively, individuals with a high value for the visible index
would have either a high BMI, a high waist circumference, a high %
body fat, or all the above. These high values in body mass or body fat
indicators could also translate into worse objective health outcomes, as
obesity is strongly associated with numerous chronic conditionsTa
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including heart disease and diabetes. If this was the case, the presence
of diseases associated with obesity among these individuals could be
influencing the way they rate their health and driving the observed
association between the visible index and SRH. Still, we believe that the
social component of the visible index would be the most likely ex-
planation here since the association between the visible index and SRH
is stronger in magnitude than the association between the disease risk
index and SRH, and all of the indicators included in the disease risk
index would be those affected by obesity.
As for our findings regarding moderation, we tested 12 different
moderation effects and found that only six of these were significant. We
proposed 10 specific hypotheses in reference to these 12 moderation
effects and found support for only four of them. This may imply that the
association between SRH and biomarker groups do not vary by gender,
age, and income to the extent hypothesized. In terms of gender, we
hypothesized that the association between SRH and biomarkers for
women vs. men would be stronger for the visible biomarkers and weaker
for the fitness biomarkers, only the first of which we found to be true.
Blaxter (1990) reported that women often describe someone healthy in
terms of being or feeling slim, whereas men are more likely to define
health in terms of physical strength. There are reports that women are
more often discriminated against because of their weight than men
(Puhl, Andreyeva, & Brownell, 2008), and are more aware of the ne-
gative health consequences of obesity (Gregory, Blanck, Gillespie,
Maynard, & Serdula, 2008). Therefore, it is reasonable to assume that
women would be more conscious about visible biomarkers when rating
their health than men. On the other hand, Okosun et al. (Okosun, Choi,
Matamoros, & Dever, 2001) found that, among a representative sample
of U.S. adults, the association between obesity and SRH was lower
among women than men, with the exception of those who identified
themselves as Hispanic. It is important to note that even though we did
not find significant differences for men vs. women in the fitness index
(interaction p-value=0.3548), the relationship between the fitness
index and SRH was stronger for men (OR=0.782,
95%CI=0.749–0.817) than women (OR=0.806,
95%CI=0.775–0.839).
We also hypothesized that the association between SRH and fatigue
biomarkers would be stronger among women than men, but we found
no significant gender moderation for the fatigue index and a trend to-
wards the opposite direction. Blaxter (1990) reported that energy was
the word most frequently used by all women when describing health,
and a population study in western Sweden found that tiredness/weak-
ness was the main symptom associated with prevalence of poor SRH,
with the association being more pronounced among women than men,
particularly among working-age adults (compared to those>65 years)
(Molarius & Janson, 2002). It is possible that the biomarkers we chose
to represent fatigue were not adequate enough to capture this concept of
“energy” or that the biomarker values in our sample were not extreme
enough to cause any fatigue-related symptoms. However, a recent
publication also based on the UKHLS sample confirmed an association
between CRP (one of the components of the fatigue index) and self-
reported fatigue, based on the question “How much of the time during the
past 4 weeks did you have a lot of energy?” contained in the Short Form
Health Survey (SF-12) (Hughes & Kumari, 2017). They also found no
gender interaction in this association, but a strong interaction for age,
as discussed below.
In terms of age, we hypothesized that the association between SRH
and fitness biomarkers would be weaker for the retired-age group
compared to working-age adults. We found a trend in the opposite di-
rection (Fig. 1), but it was not statistically significant (interaction p-
value=0.1315). Our assumption was that older respondents may
lower their expectations about their fitness levels compared to their
younger counterparts. However, it may be that we did not choose a
high enough age cut-off (60 years) for such expectations, that more
current cohorts (i.e. those born in the 1950s rather than 1920s) than
those studied by Blaxter in the 1980s do not share the same reduced
expectations, or that the biomarkers included in the fitness index were
not sufficiently different between the working-age and the retire-age
groups to influence the way they make people feel and, hence, affect the
way they rate their health. Blaxter (1990) reported that physical fitness
was the least favored concept to define health for oneself or others for
participants over 60 years, while stating that energy was an important
consideration for older men when rating their health, a report that was
supported by our finding that the association between SRH and the
fatigue index was stronger for the retired-age group compared to
working-age adults. This finding also has support in the above-
mentioned study comparing CRP and self-rated fatigue among UKHLS
participants (Hughes & Kumari, 2017); in that study, CRP was pre-
dictive of future self-reported fatigue among older (> 60 years) parti-
cipants but not among those in the younger groups.
We also hypothesized that the association between the disease risk
biomarkers and SRH would be weaker for the retired-age group com-
pared to those in the working-age group, for which we did not find
support. This result contradicts our hypothesis that older people are less
likely to consider chronic conditions when rating their own health since
the presence of disease may be more common in this group, particularly
when they compare themselves against age peers (Blaxter, 1990). The
lack of such an association may, as above, reflect different age cut-offs
or changing expectations with newer cohorts or the fact that our disease
risk index was not sensitive enough to capture those with disease con-
ditions and/or symptoms, which would influence health ratings. Jylhä,
Leskinen, Alanen, Leskinen, and Heikkinen (1986) found that one of the
best predictors of SRH among 71-75-year-old Finnish men were the
number of chronic diseases they suffered. Jylhä also noted in a later
publication that being free of serious disease is the baseline for health
assessment of younger people, whereas the evaluation context is more
complex among the elderly, with most old people negotiating “between
the normative non-problematic category of ‘good’ health and experi-
enced problems in health and functioning” (Jylhä, 2009). Along these
lines, Heller, Ahern, Pringle, and Brown (2009) found that an increase
in comorbidity over time worsened SRH, but the impact of comorbidity
change was less pronounced among older individuals.
We found mixed support for our hypotheses regarding income
moderation. For the visible index, we hypothesized that the association
with SRH would be stronger among those in the high-income group
compared to less affluent participants, which was the case (Fig. 1).
There are documented income inequalities in obesity prevalence, with
those living in the lowest income brackets having higher rates of obesity
(Booth, Charlton, & Gulliford, 2017). Therefore, our hypothesis that the
association between SRH and visible biomarkers will be stronger among
those in the highest income groups seemed appropriate given the lower
obesity prevalence and the heightened weight-related social norms in
this group (Wardle & Griffith, 2001).
We did not find support for our hypotheses of stronger SRH-fitness
and fatigue indices associations for lower income groups; on the con-
trary, the association between the fitness index and SRH was stronger
among those in the highest income tertile compared to those in the
lowest. It is possible that income is not the most appropriate measure of
SEP to investigate the hypothesized importance of fitness in low socio-
economic groups. However, when using education instead of income in
our sample, we found no significant moderation between SRH and the
fitness index (data not shown). Blaxter (1990) found that among
working-age men, health was often defined as “being able to do hard
work,” particularly among those who did manual work (Blaxter, 1990).
However, the importance of manual labor in the UK has been de-
creasing since the 1990s following deindustrialization, so Blaxter's re-
sults may not be as relevant today. In fact, being physically fit in terms
of body size and composition (i.e. being slim or having low body fat), as
opposed to “being able to do hard work” may be more relevant in
current times, in particular among high SEP groups (Wardle & Griffith,
2001).
As we hypothesized, we observed that income moderated the
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association between SRH and the disease risk index, with stronger as-
sociations among those in the high-income group. Blaxter (1990) re-
ported that health as not being ill was more commonly mentioned for
those with higher education and higher incomes. In addition, other
research suggests that less educated groups may have lower expecta-
tions, as the peers they compared themselves against when ranking
their own health have a higher-than-average prevalence of disease,
hence this may impact less on their self-assessment (Bago d’Uva,
O'Donnell, & van Doorslaer, 2008). Though it is important to note the
disease risk index is based on underlying blood analytes, and not on
whether someone has been diagnosed with a health condition.
This study has several strengths and limitations. Our sample is based
on a large representative study of residents of Great Britain, with a
diverse sample in terms of age and income, allowing us to explore as-
sociations between SRH and biomarkers across life stages and socio-
economic groups. Data on a variety of biomarkers allowed us to cate-
gorize these biomarkers into groups based on their function or likely
symptoms for a more in-depth analysis of the association between SRH
and objective health outcomes than has been explored in the literature
to date. However, the groupings were decided upon by the authors for
the purposes of this analysis, and therefore contain a subjective ele-
ment. It is possible that different groupings would have led to different
results. In addition, our focus on gender, age, and income moderation of
the association between SRH and objective health is novel. However,
we investigated effect modification by gender, age, and income in-
dividually, without accounting for possible interactions between them.
It is likely that none of the demographic factors of importance (age,
gender, income, etc.) operate in isolation to affect the relationship be-
tween objective health and SRH; therefore, future studies should in-
corporate an intersectionality perspective to study the nuances asso-
ciated with SRH responses (Brown, Richardson, Hargrove, & Thomas,
2016; Reczek, Liu, & Spiker, 2017; Veenstra, 2011). Our study did not
incorporate other possible influential factors such as race/ethnicity
(e.g. Allen, McNeely, & Orme, 2016) or sexual orientation (e.g.
Veenstra, 2011). Even though UKHLS includes a minority boost sample,
this sample was not included in the nurse visit and, therefore, our
analysis was primarily based on White/European (97%), impeding us
from carrying out analysis for racial/ethnic minorities. Finally, there
are no biomarkers reflecting psychological health, but previous
research highlights the frequency with which non-physical factors (i.e.
attitudes, emotions) are used to describe health (Benyamini et al., 2000;
Blaxter, 1990; Borawski, Kinney, & Kahana, 1996; Jylhä, 2009). Future
studies should examine objective measures of both physical and psy-
chological health in relation to SRH, and investigate if the importance
of each varies by age, gender, SEP, and/or race/ethnicity.
In conclusion, while SRH is overall strongly associated with objec-
tive measures of health, we found that the strength of this association
varies by the type of biomarker used as well as by gender, age, and
income, though the latter to a lower extent than we hypothesized.
While SRH is a valuable health indicator, caution should be taken when
using SRH as the sole health measure when studying gender, age, and
income health inequalities.
Ethical statement
Approval from the National Research Ethics Service was obtained
for data collection (Oxfordshire A REC, Reference: 10/H0604/2).
Declaration of interest
None.
Acknowledgements
Understanding Society is an initiative funded by the Economic and
Social Research Council and various Government Departments, with
scientific leadership by the Institute for Social and Economic Research,
University of Essex, and survey delivery by NatCen Social Research and
Kantar Public. The research data are distributed by the UK Data Service.
All authors were funded by ESRC while working on this paper No.
ES/M008591/1. The funder had no role in the study design, data col-
lection, analysis and interpretation of the data, in the writing of this
article, nor in the decision to submit it for publication.
References
Adams, J., & White, M. (2006). Is the disease risk associated with good self-reported
health constant across the socio-economic spectrum? Public Health, 120(1), 70–75.
Fig. 1. Effect modification by gender, age, and household income of the association between self-rated health and biomarker groups indices. Note: The
asterisk (*) denotes a significant modifying effect, based on interaction terms added between the index and the modifying variables under study. Displayed odds
ratios and 95% confidence intervals are based on stratified logistic regression analyses by gender, age, and household income groups.
M.P. Chaparro, et al. SSM - Population Health 8 (2019) 100406
9
Allen, C. D., McNeely, C. A., & Orme, J. G. (2016). Self-rated health across race, ethnicity,
and immigration status for US adolescents and young adults. Journal of Adolescent
Health, 58(1), 47–56.
Altman, C. E., Van Hook, J., & Hillemeier, M. (2016). What does self-rated health mean?
Changes and variations in the association of obesity with objective and subjective
components of self-rated health. Journal of Health and Social Behavior, 57(1), 39–58.
Bago d'Uva, T., O'Donnell, O., & van Doorslaer, E. (2008). Differential health reporting by
education level and its impact on the measurement of health inequalities among older
Europeans. International Journal of Epidemiology, 37(6), 1375–1383.
Benyamini, Y., Leventhal, E. A., & Leventhal, H. (2000). Gender differences in processing
information for making self-assessments of health. Psychosomatic Medicine, 62(3),
354–364.
Benzeval, M., Davillas, A., Kumari, M., & Lynn, P. Institute for Social and Economic
Research (ISER). (2014). Understanding society: The UK household longitudinal survey.
Biomarker user guide and glossary. Colchester, University of Essex.
Blaxter, M. (1990). Health & lifestyles. London: Routledge.
Booth, H. P., Charlton, J., & Gulliford, M. C. (2017). Socioeconomic inequality in morbid
obesity with body mass index more than 40 kg/m2 in the United States and England.
SSM - Population Health, 3, 172–178.
Borawski, E. A., Kinney, J. M., & Kahana, E. (1996). The meaning of older adults' health
appraisals: Congruence with health status and determinant of mortality. The Journals
of Gerontology Series B: Psychological Sciences and Social Sciences, 51(3), S157–S170.
Brown, T. H., Richardson, L. J., Hargrove, T. W., & Thomas, C. S. (2016). Using multiple-
hierarchy stratification and life course approaches to understand health inequalities.
Journal of Health and Social Behavior, 57(2), 200–222.
Burke, M. A., Heiland, F. W., & Nadler, C. M. (2010). From “overweight” to “about right”:
Evidence of a generational shift in body weight norms. Obesity, 18(6), 1226–1234.
Christian, L. M., Glaser, R., Porter, K., Malarkey, W. B., Beversdorf, D., & Kiecolt-Glaser, J.
K. (2011). Poorer self-rated health is associated with elevated inflammatory markers
among older adults. Psychoneuroendocrinology, 36(10), 1495–1504.
van Dalen, H., Williams, A., & Gudex, C. (1994). Lay people's evaluations of health: Are
there variations between different subgroups? Journal of Epidemiology & Community
Health, 48(3), 248–253.
Dowd, J. B., & Zajacova, A. (2010). Does self-rated health mean the same thing across
socioeconomic groups? Evidence from biomarker data. Annals of Epidemiology,
20(10), 743–749.
Gregory, C. O., Blanck, H. M., Gillespie, C., Maynard, L. M., & Serdula, M. K. (2008).
Perceived health risk of excess body weight among overweight and obese men and
women: Differences by sex. Preventive Medicine, 47(1), 46–52.
Heller, D. A., Ahern, F. M., Pringle, K. E., & Brown, T. V. (2009). Among older adults, the
responsiveness of self-rated health to changes in Charlson comorbidity was moder-
ated by age and baseline comorbidity. Journal of Clinical Epidemiology, 62(2),
177–187.
Hughes, A., & Kumari, M. (2017). Age modification of the relationship between C-reactive
protein and fatigue: Findings from understanding society (UKHLS). Psychological
Medicine, 48(8), 1341–1349.
Idler, E. L., & Benyamini, Y. (1997). Self-rated health and mortality: A review of twenty-
seven community studies. Journal of Health and Social Behavior, 38(1), 21–37.
Idler, E. L., & Kasl, S. (1991). Health perceptions and survival: Do global evaluations of
health status really predict mortality? Journal of Gerontology, 46(2), S55–S65.
Jarczok, M. N., Kleber, M. E., Koenig, J., Loerbroks, A., Herr, R. M., Hoffmann, K., et al.
(2015). Investigating the associations of self-rated health: Heart rate variability is
more strongly associated than inflammatory and other frequently used biomarkers in
a cross sectional occupational sample. PLoS One, 10(2), e0117196.
Jylhä, M. (2009). What is self-rated health and why does it predict mortality? Towards a
unified conceptual model. Social Science & Medicine, 69(3), 307–316.
Jylhä, M., Guralnik, J. M., Ferrucci, L., Jokela, J., & Heikkinen, E. (1998). Is self-rated
health comparable across cultures and genders? The Journals of Gerontology Series B:
Psychological Sciences and Social Sciences, 53(3), S144–S152.
Jylhä, M., Leskinen, E., Alanen, E., Leskinen, A. L., & Heikkinen, E. (1986). Self-rated
health and associated factors among men of different ages. Journal of Gerontology,
41(6), 710–717.
Jylhä, M., Volpato, S., & Guralnik, J. M. (2006). Self-rated health showed a graded as-
sociation with frequently used biomarkers in a large population sample. Journal of
Clinical Epidemiology, 59(5), 465–471.
Knies, G. (2015). Understanding society - UK household longitudinal study: Waves 1-5, 2009-
2014, user manual. Institute for Social and Economic Research (ISER), University of
Essex.
Langellier, B. A., Glik, D., Ortega, A. N., & Prelip, M. L. (2014). Trends in racial/ethnic
disparities in overweight self-perception among US adults, 1988-1994 and 1999-
2008. Public Health Nutrition, 18(12), 2115–2125.
Leshem-Rubinow, E., Shenhar-Tsarfaty, S., Milwidsky, A., Toker, S., Shapira, I., Berliner,
S., et al. (2015). Self-rated health is associated with elevated C-reactive protein even
among apparently healthy individuals. The Israel Medical Association Journal, 17(4),
213–218.
Lima-Costa, M. F., Cesar, C. C., Chor, D., & Proietti, F. A. (2012a). Self-rated health
compared with objectively measured health status as a tool for mortality risk
screening in older adults: 10-year follow-up of the Bambuí cohort study of aging.
American Journal of Epidemiology, 175(3), 228–235.
Lima-Costa, M. F., Steptoe, A., Cesar, C. C., De Oliveira, C., Proietti, F. A., & Marmot, M.
(2012b). The influence of socioeconomic status on the predictive power of self-rated
health for 6-year mortality in English and Brazilian older adults: The ELSA and
Bambui cohort studies. Annals of Epidemiology, 22(9), 644–648.
McFall, S., Petersen, J., Kamiska, O., & Lynn, P. Institute for Social and Economic
Research (ISER). (2014). Understanding society - the UK household longitudinal survey.
Waves 2 and 3 nurse health assessment, 2010-2012. Guide to nurse health assessment.
Colchester, University of Essex.
Medic, N., Ziauddeen, H., Forwood, S. E., Davies, K. M., Ahern, A. L., Jebb, S. A., et al.
(2016). The presence of real food usurps hypothetical health value judgment in
overweight people. eNeuro, 3(2), https://doi.org/10.1523/ENEURO.0025-16.2016.
Molarius, A., & Janson, S. (2002). Self-rated health, chronic diseases, and symptoms
among middle-aged and elderly men and women. Journal of Clinical Epidemiology,
55(4), 364–370.
Okosun, I. S., Choi, S., Matamoros, T., & Dever, G. E. A. (2001). Obesity is associated with
reduced self-rated general health status: Evidence from a representative sample of
white, black, and hispanic americans. Preventive Medicine, 32(5), 429–436.
Puhl, R. M., Andreyeva, T., & Brownell, K. D. (2008). Perceptions of weight discrimina-
tion: Prevalence and comparison to race and gender discrimination in America.
International Journal of Obesity, 32(6), 992–1000.
Quanjer, P. H., Stanojevic, S., Cole, T. J., Baur, X., Hall, G. L., Culver, B. H., et al. the ERS
Global Lung function Initiative. (2012). Multi-ethnic reference values for spirometry
for the 3-95 year age range: The Global Lung Function 2012 equations. European
Respiratory Journal, 40(6), 1324–1343.
Reczek, C., Liu, H., & Spiker, R. (2017). Self-rated health at the intersection of sexual
identity and union status. Social Science Research, 63, 242–252.
Saudny, H., Cao, Z., & Egeland, G. M. (2012). Poor self-reported health and its association
with biomarkers among Canadian Inuit. International Journal of Circumpolar Health,
71https://doi.org/10.3402/ijch.v71i0.18589.
Shanahan, L., Bauldry, S., Freeman, J., & Bondy, C. L. (2014). Self-rated health and C-
reactive protein in young adults. Brain, Behavior, and Immunity, 36, 139–146.
Shooshtari, S., Menec, V., & Tate, R. (2007). Comparing predictors of positive and ne-
gative self-rated health between younger (25-54) and older (55+) Canadian adults: A
longitudinal study of well-being. Research on Aging, 29(6), 512–554.
Tanno, K., Ohsawa, M., Onoda, T., Itai, K., Sakata, K., Tanaka, F., et al. (2012). Poor self-
rated health is significantly associated with elevated C-reactive protein levels in
women, but not in men, in the Japanese general population. Journal of Psychosomatic
Research, 73(3), 225–231.
Undén, A. L., Andréasson, A., Elofsson, S., Brismar, K., Mathsson, L., Rönnelid, J., et al.
(2007). Inflammatory cytokines, behaviour and age as determinants of self-rated
health in women. Clinical Science, 112(6), 363–373.
University of Essex (2014). Institute for social and economic research and national centre for
social researchUnderstanding Society: Waves 2 and 3 Nurse Health Assessment, 2010-
2012 [data collection] (3rd ed.). UK Data Service. SN:7251 http://doi.org/10.5255/
UKDA-SN-7251-3.
University of Essex (2015). Institute for social and economic research, NatCen social research,
Kantar publicUnderstanding Society: Waves 1-5, 2009-2014. [data collection] (7th
ed.). UK Data Service. SN: 6614 http://doi.org/10.5255/UKDA-SN-6614-07.
Veenstra, G. (2011). Race, gender, class, and sexual orientation: Intersecting axes of in-
equality and self-rated health in Canada. International Journal for Equity in Health,
10(1), 3.
Wardle, J., & Griffith, J. (2001). Socioeconomic status and weight control practices in
British adults. Journal of Epidemiology & Community Health, 55(3), 185–190.
M.P. Chaparro, et al. SSM - Population Health 8 (2019) 100406
10
